Infographic: Selected deals for SARS-CoV-2 vaccines in late stage development

Did you know Canada has secured deals with all six of the leading vaccine candidates in development, as well as one domestic manufacturer?

With these agreements in place, Canada has purchased the highest number of vaccines (per capita) for the prevention of SARS-CoV-2 infection. If all of the vaccines are successful, Canada will have secured enough doses to vaccinate the entire population at 100% coverage rate, five times over.

Selected deals for SARS-CoV-2 vaccines in late stage development
Selected deals for SARS-CoV-2 vaccines in late stage development

Did you know Canada has secured deals with all six of the leading vaccine candidates in development, as well as one domestic manufacturer?

With these agreements in place, Canada has purchased the highest number of vaccines (per capita) for the prevention of SARS-CoV-2 infection. If all of the vaccines are successful, Canada will have secured enough doses to vaccinate the entire population at 100% coverage rate, five times over.

In our latest infographic, we present a selection of some of the confirmed procurement deals from higher-income countries.

Download the infographic

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here